Healthcare - Biotechnology - NASDAQ - CN
$ 1.11
11 %
$ 61.3 M
Market Cap
-2.85
P/E
BALANCE SHEET
126 M
ASSETS
24.8 M
LIABILITIES
101 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Connect Biopharma Holdings Limited
| Current Assets | 121 M |
| Cash & Short-Term Investments | 119 M |
| Receivables | 51 K |
| Other Current Assets | 2.27 M |
| Non-Current Assets | 4.92 M |
| Long-Term Investments | 0 |
| PP&E | 4.73 M |
| Other Non-Current Assets | 194 K |
| Current Liabilities | 24.3 M |
| Accounts Payable | 7.66 M |
| Short-Term Debt | 285 K |
| Other Current Liabilities | 16.3 M |
| Non-Current Liabilities | 585 K |
| Long-Term Debt | 180 K |
| Other Non-Current Liabilities | 405 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 106.0 | 80.4 | 268.0 | 154.7 | 44.8 | 61.3 |
| Short Term Investments | 12.6 | 74.7 | 677 | 2.0 | 4.4 | 0.4 |
| Receivables | 51 K | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (6.4) | 6.74 K | 4.9 | 3.2 | 0 |
| Other Current Assets | 2.1 | 3.1 | 7.4 | 4.9 | 2.5 | 2.4 |
| Total Current Assets | 121.0 | 158.5 | 275.4 | 161.9 | 52.6 | 68.1 |
| PP&E | 4.7 | 5.5 | 12.9 | 2.7 | 0.5 | 0.5 |
| Intangible Assets | 62 K | 3.2 | 3.5 | 52.4 K | 0 | 0 |
| Goodwill | 0 | 0 | (3.5) | 0 | 0 | 0 |
| Long Term Investments | 0 | 9.6 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.1 | 34.6 K | 3.0 | 1.6 | 0.9 | 0.7 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 125.9 | 177.0 | 291.4 | 166.2 | 54.1 | 69.3 |
| LIABILITIES | ||||||
| Accounts Payable | 7.7 | 11.9 | 12.7 | 3.8 | 3.3 | 0.5 |
| Short Term Debt | 0.3 | 0.2 | 99 K | 0.2 | 58.9 K | 57 K |
| Other Current Liabilities | 3.0 | 3.5 | 5.2 | 1.9 | 0.6 | 0.4 |
| Total Current Liabilities | 24.3 | 15.9 | 18.0 | 5.8 | 4.0 | 1.0 |
| Long Term Debt | 0.2 | 0.2 | 26 K | 47.3 K | 67.2 K | 87.9 |
| Deferred Tax Income | 0 | (0.7) | (0.8) | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0.8 | 317.3 | 91.9 | (0.1) |
| Total Liabilities | 24.8 | 16.8 | 18.8 | 323.2 | 97.3 | 88.7 |
| EQUITY | ||||||
| Common Stock | 10 K | 9.64 K | 10.4 K | 3.68 K | 3.05 K | 3.21 K |
| Retained Earnings | (539.3) | (463.8) | (373.4) | (164.1) | (42.4) | (18.9) |
| Other Accumulative Comprehensive Income/Loss | 11.9 | 10.4 | (6.5) | (0.3) | (7.1) | (6.4) |
| Total Equity | 101.0 | (463.8) | 272.6 | (157.0) | (43.3) | (19.4) |
| Total Liabilities and Equity | 125.9 | (447.0) | 291.4 | 166.2 | 54.1 | 69.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 55.1 | 55.0 | 52.3 | 53.9 | 55.8 |